AbCellera Biologics Inc.ABCLNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+20.5%
5Y CAGR+85.4%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+20.5%/yr
vs +114.8%/yr prior
5Y CAGR
+85.4%/yr
Recent deceleration
Acceleration
-94.3pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
21.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$39.51M-65.5%
2024$114.37M+81.0%
2023$63.18M+179.7%
2022$22.59M+53.3%
2021$14.74M+717.8%
2020$1.80M-5.5%
2019$1.91M+79.5%
2018$1.06M-